Active 0 6 0 6 O
bleeding 7 15 7 15 O
or 16 18 16 18 O
high 19 23 19 23 O
risk 24 28 24 28 O
for 29 32 29 32 O
bleeding 33 41 33 41 O
( 42 43 42 43 O
e.g. 43 47 43 47 O
known 48 53 48 53 O
acute 54 59 54 59 O
gastrointestinal 60 76 60 76 B-chronic_disease
ulcer 77 82 77 82 I-chronic_disease
) 82 83 82 83 O

Because 0 7 84 91 O
limited 8 15 92 99 O
dosing 16 22 100 106 O
or 23 25 107 109 O
adverse 26 33 110 117 O
event 34 39 118 123 O
data 40 44 124 128 O
are 45 48 129 132 O
currently 49 58 133 142 O
available 59 68 143 152 O
on 69 71 153 155 O
the 72 75 156 159 O
use 76 79 160 163 O
of 80 82 164 166 O
isoquercetin 83 95 167 179 B-treatment
in 96 98 180 182 O
participants 99 111 183 195 O
< 112 113 196 197 O
18 113 115 197 199 B-upper_bound
years 116 121 200 205 I-upper_bound
of 122 124 206 208 O
age 125 128 209 212 B-age

Current 0 7 213 220 O
daily 8 13 221 226 O
use 14 17 227 230 O
of 18 20 231 233 O
aspirin 21 28 234 241 B-treatment
( 29 30 242 243 O
> 30 31 243 244 O
81 31 33 244 246 B-lower_bound
mg 33 35 246 248 I-lower_bound
daily 36 41 249 254 O
) 41 42 254 255 O
, 42 43 255 256 O
Clopidogrel 44 55 257 268 B-treatment
( 56 57 269 270 I-treatment
Plavix 57 63 270 276 I-treatment
) 63 64 276 277 I-treatment
, 64 65 277 278 O
cilostazol 66 76 279 289 B-treatment
( 77 78 290 291 I-treatment
Pletal 78 84 291 297 I-treatment
) 84 85 297 298 I-treatment
, 85 86 298 299 O
aspirin 87 94 300 307 B-treatment
- 94 95 307 308 I-treatment
dipyridamole 95 107 308 320 I-treatment
( 108 109 321 322 I-treatment
Aggrenox 109 117 322 330 I-treatment
) 117 118 330 331 I-treatment
( 119 120 332 333 O
within 120 126 333 339 O
10 127 129 340 342 B-upper_bound
days 130 134 343 347 I-upper_bound
) 134 135 347 348 O
or 136 138 349 351 O
considered 139 149 352 362 O
to 150 152 363 365 O
use 153 156 366 369 O
regular 157 164 370 377 O
use 165 168 378 381 O
of 169 171 382 384 O
higher 172 178 385 391 O
doses 179 184 392 397 O
of 185 187 398 400 O
non 188 191 401 404 B-treatment
- 191 192 404 405 I-treatment
steroidal 192 201 405 414 I-treatment
anti 202 206 415 419 I-treatment
- 206 207 419 420 I-treatment
inflammatory 207 219 420 432 I-treatment
agents 220 226 433 439 I-treatment
as 227 229 440 442 O
determined 230 240 443 453 O
by 241 243 454 456 O
the 244 247 457 460 O
treating 248 256 461 469 O
physician 257 266 470 479 O
( 267 268 480 481 O
e.g 268 271 481 484 O
ibuprofen 272 281 485 494 B-treatment
> 282 283 495 496 O
800 284 287 497 500 B-lower_bound
mg 288 290 501 503 I-lower_bound
daily 291 296 504 509 O
or 297 299 510 512 O
equivalent 300 310 513 523 O
) 310 311 523 524 O

Currently 0 9 525 534 O
receiving 10 19 535 544 O
anticoagulant 20 33 545 558 B-treatment
therapy 34 41 559 566 I-treatment

ECOG 0 4 567 571 B-clinical_variable
performance 5 16 572 583 I-clinical_variable
status 17 23 584 590 I-clinical_variable
â‰¤2 24 26 591 593 O

Familial 0 8 594 602 B-chronic_disease
bleeding 9 17 603 611 I-chronic_disease
diathesis 18 27 612 621 I-chronic_disease

History 0 7 622 629 O
of 8 10 630 632 O
significant 11 22 633 644 O
hemorrhage 23 33 645 655 B-chronic_disease
( 34 35 656 657 O
requiring 35 44 657 666 O
hospitalization 45 60 667 682 O
or 61 63 683 685 O
transfusion 64 75 686 697 B-treatment
) 75 76 697 698 O
outside 77 84 699 706 O
of 85 87 707 709 O
a 88 89 710 711 O
surgical 90 98 712 720 O
setting 99 106 721 728 O
within 107 113 729 735 O
the 114 117 736 739 O
last 118 122 740 744 B-upper_bound
24 123 125 745 747 I-upper_bound
months 126 132 748 754 I-upper_bound

Known 0 5 755 760 O
diagnosis 6 15 761 770 O
of 16 18 771 773 O
disseminated 19 31 774 786 B-chronic_disease
intravascular 32 45 787 800 I-chronic_disease
coagulation 46 57 801 812 I-chronic_disease
( 58 59 813 814 I-chronic_disease
DIC 59 62 814 817 I-chronic_disease
) 62 63 817 818 I-chronic_disease

Known 0 5 819 824 O
intolerance 6 17 825 836 O
of 18 20 837 839 O
niacin 21 27 840 846 B-treatment
or 28 30 847 849 O
ascorbic 31 39 850 858 B-treatment
acid 40 44 859 863 I-treatment
( 45 46 864 865 O
including 46 55 865 874 O
known 56 61 875 880 O
G6PD 62 66 881 885 B-chronic_disease
deficiency 67 77 886 896 I-chronic_disease
) 77 78 896 897 O

Life 0 4 898 902 B-clinical_variable
expectancy 5 15 903 913 I-clinical_variable
of 16 18 914 916 O
greater 19 26 917 924 O
than 27 31 925 929 O
4 32 33 930 931 B-lower_bound
months 34 40 932 938 I-lower_bound

Minimum 0 7 939 946 O
age 8 11 947 950 B-age
18 12 14 951 953 B-lower_bound
years 15 20 954 959 I-lower_bound

Participants 0 12 960 972 O
must 13 17 973 977 O
have 18 22 978 982 O
histologically 23 37 983 997 O
confirmed 38 47 998 1007 O
malignancy 48 58 1008 1018 B-cancer
that 59 63 1019 1023 O
is 64 66 1024 1026 O
metastatic 67 77 1027 1037 O
or 78 80 1038 1040 O
currently 81 90 1041 1050 O
unresectable 91 103 1051 1063 O

Participants 0 12 1064 1076 O
with 13 17 1077 1081 O
known 18 23 1082 1087 O
brain 24 29 1088 1093 B-cancer
metastases 30 40 1094 1104 I-cancer
should 41 47 1105 1111 O
be 48 50 1112 1114 O
excluded 51 59 1115 1123 O
from 60 64 1124 1128 O
this 65 69 1129 1133 O
clinical 70 78 1134 1142 B-treatment
trial 79 84 1143 1148 I-treatment
because 85 92 1149 1156 O
of 93 95 1157 1159 O
their 96 101 1160 1165 O
poor 102 106 1166 1170 O
prognosis 107 116 1171 1180 O
and 117 120 1181 1184 O
because 121 128 1185 1192 O
they 129 133 1193 1197 O
often 134 139 1198 1203 O
develop 140 147 1204 1211 O
progressive 148 159 1212 1223 O
neurologic 160 170 1224 1234 B-chronic_disease
dysfunction 171 182 1235 1246 I-chronic_disease
that 183 187 1247 1251 O
would 188 193 1252 1257 O
confound 194 202 1258 1266 O
the 203 206 1267 1270 O
evaluation 207 217 1271 1281 O
of 218 220 1282 1284 O
neurologic 221 231 1285 1295 O
and 232 235 1296 1299 O
other 236 241 1300 1305 O
adverse 242 249 1306 1313 O
events 250 256 1314 1320 O

Pregnant 0 8 1321 1329 B-pregnancy
women 9 14 1330 1335 B-gender
are 15 18 1336 1339 O
excluded 19 27 1340 1348 O
from 28 32 1349 1353 O
this 33 37 1354 1358 O
study 38 43 1359 1364 O
because 44 51 1365 1372 O
isoquercetin 52 64 1373 1385 B-treatment
is 65 67 1386 1388 O
a 68 69 1389 1390 O
PDI 70 73 1391 1394 B-treatment
inhibitor 74 83 1395 1404 I-treatment
with 84 88 1405 1409 O
the 89 92 1410 1413 O
potential 93 102 1414 1423 O
for 103 106 1424 1427 O
teratogenic 107 118 1428 1439 O
or 119 121 1440 1442 O
abortifacient 122 135 1443 1456 O
effects 136 143 1457 1464 O
. 143 144 1464 1465 O
Because 145 152 1466 1473 O
there 153 158 1474 1479 O
is 159 161 1480 1482 O
an 162 164 1483 1485 O
unknown 165 172 1486 1493 O
but 173 176 1494 1497 O
potential 177 186 1498 1507 O
risk 187 191 1508 1512 O
of 192 194 1513 1515 O
adverse 195 202 1516 1523 O
events 203 209 1524 1530 O
in 210 212 1531 1533 O
nursing 213 220 1534 1541 O
infants 221 228 1542 1549 O
secondary 229 238 1550 1559 O
to 239 241 1560 1562 O
treatment 242 251 1563 1572 B-treatment
of 252 254 1573 1575 O
the 255 258 1576 1579 O
mother 259 265 1580 1586 O
with 266 270 1587 1591 O
isoquercetin 271 283 1592 1604 O
, 283 284 1604 1605 O
breastfeeding 285 298 1606 1619 O
should 299 305 1620 1626 O
be 306 308 1627 1629 O
discontinued 309 321 1630 1642 O
if 322 324 1643 1645 O
the 325 328 1646 1649 O
mother 329 335 1650 1656 O
is 336 338 1657 1659 O
treated 339 346 1660 1667 O
with 347 351 1668 1672 O
isoquercetin 352 364 1673 1685 O
. 364 365 1685 1686 O
These 366 371 1687 1692 O
potential 372 381 1693 1702 O
risks 382 387 1703 1708 O
may 388 391 1709 1712 O
also 392 396 1713 1717 O
apply 397 402 1718 1723 O
to 403 405 1724 1726 O
other 406 411 1727 1732 O
agents 412 418 1733 1739 O
used 419 423 1740 1744 O
in 424 426 1745 1747 O
this 427 431 1748 1752 O
study 432 437 1753 1758 O

Prior 0 5 1759 1764 O
history 6 13 1765 1772 O
of 14 16 1773 1775 O
documented 17 27 1776 1786 O
venous 28 34 1787 1793 B-chronic_disease
thromboembolic 35 49 1794 1808 I-chronic_disease
event 50 55 1809 1814 O
within 56 62 1815 1821 O
the 63 66 1822 1825 O
last 67 71 1826 1830 B-upper_bound
2 72 73 1831 1832 I-upper_bound
years 74 79 1833 1838 I-upper_bound

Receiving 0 9 1839 1848 O
or 10 12 1849 1851 O
scheduled 13 22 1852 1861 O
to 23 25 1862 1864 O
receive 26 33 1865 1872 O
first 34 39 1873 1878 B-treatment
or 40 42 1879 1881 I-treatment
second 43 49 1882 1888 I-treatment
line 50 54 1889 1893 I-treatment
chemotherapy 55 67 1894 1906 I-treatment
( 68 69 1907 1908 O
within 69 75 1908 1914 O
30 76 78 1915 1917 B-upper_bound
days 79 83 1918 1922 I-upper_bound
of 84 86 1923 1925 O
registration 87 99 1926 1938 O
) 99 100 1938 1939 O

Uncontrolled 0 12 1940 1952 O
intercurrent 13 25 1953 1965 B-chronic_disease
illness 26 33 1966 1973 I-chronic_disease
including 34 43 1974 1983 O
, 43 44 1983 1984 O
but 45 48 1985 1988 O
not 49 52 1989 1992 O
limited 53 60 1993 2000 O
to 61 63 2001 2003 O
ongoing 64 71 2004 2011 O
or 72 74 2012 2014 O
active 75 81 2015 2021 B-chronic_disease
infection 82 91 2022 2031 I-chronic_disease
, 91 92 2031 2032 O
symptomatic 93 104 2033 2044 O
congestive 105 115 2045 2055 B-chronic_disease
heart 116 121 2056 2061 I-chronic_disease
failure 122 129 2062 2069 I-chronic_disease
, 129 130 2069 2070 O
unstable 131 139 2071 2079 O
angina 140 146 2080 2086 B-chronic_disease
pectoris 147 155 2087 2095 I-chronic_disease
, 155 156 2095 2096 O
cardiac 157 164 2097 2104 O
arrhythmia 165 175 2105 2115 B-chronic_disease
, 175 176 2115 2116 O
or 177 179 2117 2119 O
psychiatric 180 191 2120 2131 B-chronic_disease
illness 192 199 2132 2139 I-chronic_disease
/ 199 200 2139 2140 O
social 200 206 2140 2146 O
situations 207 217 2147 2157 O
that 218 222 2158 2162 O
would 223 228 2163 2168 O
limit 229 234 2169 2174 O
compliance 235 245 2175 2185 O
with 246 250 2186 2190 O
study 251 256 2191 2196 O
requirements 257 269 2197 2209 O

central 0 7 2210 2217 O
line 8 12 2218 2222 O
associated 13 23 2223 2233 O
events 24 30 2234 2240 O
whereby 31 38 2241 2248 O
patients 39 47 2249 2257 O
completed 48 57 2258 2267 O
anticoagulation 58 73 2268 2283 B-treatment

women 0 5 2284 2289 B-gender
of 6 8 2290 2292 O
child 9 14 2293 2298 O
- 14 15 2298 2299 O
bearing 15 22 2299 2306 O
potential 23 32 2307 2316 O
and 33 36 2317 2320 O
men 37 40 2321 2324 O
must 41 45 2325 2329 O
agree 46 51 2330 2335 B-contraception_consent
to 52 54 2336 2338 I-contraception_consent
use 55 58 2339 2342 I-contraception_consent
adequate 59 67 2343 2351 I-contraception_consent
contraception 68 81 2352 2365 I-contraception_consent
( 82 83 2366 2367 O
hormonal 83 91 2367 2375 O
or 92 94 2376 2378 O
barrier 95 102 2379 2386 O
method 103 109 2387 2393 O
of 110 112 2394 2396 O
birth 113 118 2397 2402 O
control 119 126 2403 2410 O
; 126 127 2410 2411 O
abstinence 128 138 2412 2422 O
) 138 139 2422 2423 O
prior 140 145 2424 2429 O
to 146 148 2430 2432 O
study 149 154 2433 2438 O
entry 155 160 2439 2444 O
and 161 164 2445 2448 O
for 165 168 2449 2452 O
the 169 172 2453 2456 O
duration 173 181 2457 2465 O
of 182 184 2466 2468 O
study 185 190 2469 2474 O
participation 191 204 2475 2488 O

